Siegfried
Siegfried is seeking a visionary Lab Head Pharmaceutical Development to lead the design, construction, and scaling of new formulation and process development laboratories within a global CDMO environment. The role involves defining innovative drug development strategies and implementing cutting-edge technologies to shape the future of pharmaceutical development.
Headquarters
Zofingen, Aargau, Switzerland
Company Size
1001-5000 employees
Founded
1873
Siegfried is your trusted global CDMO partner. Offering development and manufacturing from early-phase to commercial, from drug substance to drug product.
UPDATE: Noramco divestment continues as it re-establishes CDMO Halo Pharma
1 month ago
Siegfried to get 2 new US sites with purchase of Noramco
1 month ago
Remembering Siegfried Brockmann, who escaped from East Germany in 1948 and became a VP at Cole Chemical Company
Jan 6, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Siegfried.
35% below the average for this role
SK Capital Partners Announces Agreement to Sell Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG
1 month ago
Director, Pharmaceutical Development
Nurix
Principal Scientist in Pharmaceutical Development
IQVIA
Associate Scientist - Oral Solid Dosage Formulation
SOKOL GxP Services
Pharmaceutical Development Lead Scientist I
Catalent
Pesquisador(a) de Desenvolvimento Galênico Nível Sênior - Divisão de Farmacêuticos Estabelecidos/Centro de Desenvolvimento (EPD-M) - Rio de Janeiro/RJ
Abbott Laboratories
Senior Scientist, Drug Product Development
Alumis